Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 6 studies | 24% ± 5% | |
| epithelial cell | 5 studies | 25% ± 10% | |
| astrocyte | 4 studies | 18% ± 2% | |
| fibroblast | 3 studies | 20% ± 3% | |
| oligodendrocyte precursor cell | 3 studies | 17% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 17% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 718.18 | 245 / 245 | 96% | 2.03 | 480 / 502 |
| brain | 98% | 223.09 | 2593 / 2642 | 95% | 2.60 | 670 / 705 |
| thymus | 100% | 689.45 | 653 / 653 | 89% | 2.18 | 537 / 605 |
| breast | 100% | 524.85 | 459 / 459 | 75% | 1.60 | 835 / 1118 |
| kidney | 100% | 343.24 | 89 / 89 | 68% | 1.32 | 613 / 901 |
| ovary | 100% | 917.78 | 180 / 180 | 67% | 1.25 | 288 / 430 |
| pancreas | 99% | 278.44 | 326 / 328 | 64% | 1.02 | 114 / 178 |
| adrenal gland | 100% | 372.76 | 258 / 258 | 61% | 0.98 | 141 / 230 |
| bladder | 100% | 544.86 | 21 / 21 | 35% | 0.55 | 175 / 504 |
| uterus | 99% | 711.71 | 169 / 170 | 35% | 0.61 | 162 / 459 |
| skin | 89% | 276.87 | 1611 / 1809 | 45% | 0.80 | 211 / 472 |
| lung | 96% | 294.44 | 556 / 578 | 36% | 0.58 | 417 / 1155 |
| esophagus | 97% | 404.82 | 1407 / 1445 | 32% | 0.49 | 58 / 183 |
| stomach | 100% | 375.65 | 358 / 359 | 22% | 0.31 | 63 / 286 |
| intestine | 100% | 487.48 | 965 / 966 | 21% | 0.32 | 112 / 527 |
| liver | 96% | 229.00 | 218 / 226 | 17% | 0.26 | 68 / 406 |
| ureter | 0% | 0 | 0 / 0 | 100% | 1.08 | 1 / 1 |
| blood vessel | 100% | 368.73 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 340.95 | 240 / 241 | 0% | 0 | 0 / 0 |
| muscle | 100% | 318.77 | 799 / 803 | 0% | 0 | 0 / 0 |
| adipose | 99% | 391.88 | 1195 / 1204 | 0% | 0 | 0 / 0 |
| heart | 96% | 231.47 | 827 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 47% | 56.72 | 438 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 35% | 0.68 | 28 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 24% | 0.37 | 7 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 9% | 0.13 | 4 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005634 | Cellular component | nucleus |
| GO_0003677 | Molecular function | DNA binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| Gene name | GTF2IRD2 |
| Protein name | GTF2I repeat domain containing 2 General transcription factor II-I repeat domain-containing protein 2A (GTF2I repeat domain-containing protein 2A) (Transcription factor GTF2IRD2-alpha) General transcription factor II-I repeat domain-containing protein 2A |
| Synonyms | GTF2IRD2A |
| Description | |
| Accessions | ENST00000614386.1 [Q86UP8-4] Q86UP8 ENST00000625377 ENST00000651129.1 A0A494C0I1 ENST00000451013.7 [Q86UP8-1] A0A0D9SF80 |
